Instruments for nucleic acid purification/isolation
Location: Singapore
Employees: 1-10
Total raised: $5M
Founded date: 2015
Investors 1
| Date | Name | Website |
| 17.07.2021 | ARCH Ventu... | archventur... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.07.2019 | Series A | $5M | - |
Mentions in press and media 4
| Date | Title | Description |
| 25.09.2024 | CariGenetics And One BioMed Strike Partnership to Advance Genomic Testing in the Caribbean - Decentralised Approach Serves the Needs of the Caribbean Community | HAMILTON, Bermuda, Sept. 25, 2024 /PRNewswire/ -- CariGenetics and One BioMed are proud to announce their strategic partnership to bring One BioMed's Xceler8 Platform across the Caribbean. Implementing this cutting-edge technology in the re... |
| 22.05.2023 | One BioMed Announce World's First Fully Integrated Platform for Automated High Molecular Weight DNA Extraction | Beyond Simple HMW DNA extraction at scale. SINGAPORE, May 22, 2023 /PRNewswire/ -- One BioMed, announced today the launch of the X8™ HMW DNA Cartridge Kits for the automated extraction of high molecular weight DNA for use in long-read seque... |
| 10.11.2021 | One BioMed launches the cartridge-based Xceler8(TM) Nucleic Acid Extraction Platform, the next generation in workflow simplification | SINGAPORE, Nov. 10, 2021 /PRNewswire/ -- One BioMed, a company focused on advancing human health through innovation, announced today the launch of their Xceler8™ Platform for high-yield extraction and purification of nucleic acids from biol... |
| 10.07.2019 | One BioMed Closes US$5M Series A Funding | One BioMed Pte Ltd, a Singapore-based healthcare startup, closed a US$5M Series A funding round. The round was led by Biopath Ventures and US-based ARCH Venture Partners, with Enterprise Singapore’s investment arm, SEEDS Capital, also parti... |